Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

Abroad (travel likely)Recruiting

Conditions

Chronic Hepatitis B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Minghui Li, Dr) · wuhm2000@sina.com · +8613693259096

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Cancer · Liver Cirrhosis · Chronic Hepatitis

Abroad (travel likely)Recruiting

Redondo Beach, United States · Coon Rapids, United States

ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis b

Abroad (travel likely)RecruitingPHASE4

Chongqing, China

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Hepatitis B · Viral Hepatitis

Abroad (travel likely)RecruitingPHASE4

Taichung, Taiwan